Antiviral agents.
Potent effective antiviral drugs recently have been licensed for several viral diseases, ushering in a new era in the treatment of viral diseases. Several unique features in the process of a viral infection have been identified as target points for inhibition. The unique steps and the interfering compounds are the subject of this review.
Reines
E D
ED
Division of Infectious Diseases, Hackensack Medical Center, New Jersey.
Gross
P A
PA
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D000212:Acyclovir / Q000009:adverse effects / Q000031:analogs & derivatives / Q000493:pharmacokinetics / Q000627:therapeutic use; D000547:Amantadine / Q000627:therapeutic use; D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use; D015774:Ganciclovir; D006801:Humans; D012254:Ribavirin / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D014740:Vidarabine / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D014777:Virus Diseases / Q000188:drug therapy*
D000998:Antiviral Agents; D012254:Ribavirin; D000547:Amantadine; D014740:Vidarabine; D015774:Ganciclovir; D000212:Acyclovir